CD73: a new biomarker in triple-negative breast cancer

被引：4
作者：
Lafont, Virginie [1 ,2 ]
Michaud, Henri-Alexandre [1 ,2 ]
Bonnefoy, Nathalie [1 ,2 ]
机构：
[1] INSERM, IRCM, Montpellier, France
[2] Univ Montpellier, Inst Reg Canc Montpellier ICM, Montpellier, France
来源：
TRANSLATIONAL CANCER RESEARCH | 2018年 / 7卷
关键词：
CLINICAL-SIGNIFICANCE; POOR-PROGNOSIS; EXPRESSION; CARCINOMA; MIGRATION; CELLS;
D O I：
10.21037/tcr.2018.05.22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S594 / S596
页数：3
相关论文
共 21 条
  • [1] Anti-CD73 immunotherapy: A viable way to reprogram the tumor microenvironment
    Antonioli, Luca
    Blandizzi, Corrado
    Malavasi, Fabio
    Ferrari, Davide
    Hasko, Gyoergy
    [J]. ONCOIMMUNOLOGY, 2016, 5 (09):
  • [2] Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities
    Antonioli, Luca
    Yegutkin, Gennady G.
    Pacher, Pal
    Blandizzi, Corrado
    Hasko, Gyorgy
    [J]. TRENDS IN CANCER, 2016, 2 (02): : 95 - 109
  • [3] Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
    Buisseret, L.
    Pommey, S.
    Allard, B.
    Garaud, S.
    Bergeron, M.
    Cousineau, I.
    Ameye, L.
    Bareche, Y.
    Paesmans, M.
    Crown, J. P. A.
    Di Leo, A.
    Loi, S.
    Piccart-Gebhart, M.
    Willard-Gallo, K.
    Sotiriou, C.
    Stagg, J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (04) : 1056 - 1062
  • [4] Triple-Negative Breast Cancer
    Foulkes, William D.
    Smith, Ian E.
    Reis-Filho, Jorge S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (20) : 1938 - 1948
  • [5] CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity
    Gao, Zhao-wei
    Wang, Hui-ping
    Lin, Fang
    Wang, Xi
    Long, Min
    Zhang, Hui-zhong
    Dong, Ke
    [J]. BMC CANCER, 2017, 17
  • [6] The Roles of CD73 in Cancer
    Gao, Zhao-wei
    Dong, Ke
    Zhang, Hui-zhong
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [7] Targeting CD73 in the tumor microenvironment with MEDI9447
    Hay, Carl M.
    Sult, Erin
    Huang, Qihui
    Mulgrew, Kathy
    Fuhrmann, Stacy R.
    McGlinchey, Kelly A.
    Hammond, Scott A.
    Rothstein, Raymond
    Rios-Doria, Jonathan
    Poon, Edmund
    Holoweckyj, Nick
    Durham, Nicholas M.
    Leow, Ching Ching
    Diedrich, Gundo
    Damschroder, Melissa
    Herbst, Ronald
    Hollingsworth, Robert E.
    Sachsenmeier, Kris F.
    [J]. ONCOIMMUNOLOGY, 2016, 5 (08):
  • [8] Comprehensive evaluation of NT5E/CD73 expression and its prognostic significance in distinct types of cancers
    Jiang, Tao
    Xu, Xiaofeng
    Qiao, Meng
    Li, Xuefei
    Zhao, Chao
    Zhou, Fei
    Gao, Guanghui
    Wu, Fengying
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Zhai, Changyun
    Zhou, Caicun
    [J]. BMC CANCER, 2018, 18
  • [9] CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
    Leclerc, Bruno G.
    Charlebois, Roxanne
    Chouinard, Guillaume
    Allard, Bertrand
    Pommey, Sandra
    Saad, Fred
    Stagg, John
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (01) : 158 - 166
  • [10] Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
    Lee, Alice
    Djamgoz, Mustafa B. A.
    [J]. CANCER TREATMENT REVIEWS, 2018, 62 : 110 - 122
123